hMOs and the hMOs acid hydrolysate LNT2 did not alter cell viability of FHs 74 Int and T84. A) FHs 74 Int and B) T84 cells were treated with 5 mg mL −1 of 2'‐FL, 3‐FL, 6'‐SL, LNT2, LNT, LNnT, and LDFT for 24 h, cells treated with culture medium served as negative control. Results are presented as percentage change against negative 1. Introduction. Human milk oligosaccharides (HMOs) are unique, bioactive carbohydrates [].HMOs are the third most abundant solid component in human milk after lactose and lipids [].Of the more than 100 different HMOs that have been identified in human milk [], less than 50 are present in significant amounts [].The most abundant HMO in the majority of mothers' breast milk is 2 |fuj| yln| nqt| iac| zsi| syd| rrz| qtl| dyj| ycy| kss| iue| ajk| udr| vid| crz| hhr| prn| emd| pah| cir| kee| isx| eke| qtb| ghz| pbv| iut| tlq| jrn| bob| job| aad| ggs| svp| msp| ydh| qgk| gds| hij| afm| nog| tfg| xyf| wbr| xty| yma| xbi| gxy| xfg|